Home/Corteria Pharmaceuticals/Régis Olivier

RO

Régis Olivier

CAO

Corteria Pharmaceuticals

Roles

CAOatCorteria Pharmaceuticals

CFOatTridek-One

Therapeutic Areas

Cardiovascular Metabolic Disorders Musculoskeletal

Corteria Pharmaceuticals Pipeline

Drug	Indication	Phase
COR-1167	Worsening Heart Failure	Phase 2
COR-1389	Obesity and Right Heart Failure	Phase 1
Vasopressin Neutralizing Antibody	Heart Failure (implied)	Preclinical

Leadership Team at Corteria Pharmaceuticals

Marie-Laure Ozoux

Francesca C. Lawson

View full Corteria Pharmaceuticals profile